The Effects of CO2 Pneumoperitoneum at Different Temperature in Laparoscopic Surgery
Benign Neoplasm of Cervix Uteri, Gynecological Laparoscopy
About this trial
This is an interventional health services research trial for Benign Neoplasm of Cervix Uteri focused on measuring Gynecological laparoscopy, standard CO2, heated-humidified CO2, hemodynamic parameters, respiratory parameters
Eligibility Criteria
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) physical status I-II patients aged 40-65 who underwent laparoscopic hysterectomy for benign pathology.
Exclusion Criteria:
- Patients with chronic obstructive pulmonary disease, asthma, advanced liver and kidney disease, infection, bleeding disorder and drug allergies
Sites / Locations
- Asuman Sargin
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Group HH (heated-humidified) patients
Group CD (cold-dry) patients
Group HH (heated-humidified) patients were administered 95% humidified CO2 insufflation at 37°C. All patients were given information and training on the anesthesia method, the use of the patient-controlled-analgesia (PCA) device and the visual analog scale (VAS) the day before the operation. The patients' demographic data (age, weight, height, etc.) and their basal systolic, diastolic and mean blood pressures and heart rates were measured prior to the operation and recorded on the case report form.
Group CD (cold-dry) patients were administered dry CO2 via insufflator at room temperature (21°C). All patients were given information and training on the anesthesia method, the use of the patient-controlled-analgesia (PCA) device and the visual analog scale (VAS) the day before the operation. The patients' demographic data (age, weight, height, etc.) and their basal systolic, diastolic and mean blood pressures and heart rates were measured prior to the operation and recorded on the case report form.